Scientific News
Larger studies with longer follow-ups are needed to assess whether and how VMT influences neurodevelopment.
The findings show that bacterial metabolites can sensitize cancer cells to treatment with immunotherapy by boosting the expression of HLA class I molecules.
George Paraskevakos, Executive Director at International Probiotics Association, discusses the future of the microbiome space.
Analyzing how different exposures affect the infant gut microbiota could help researchers identify confounding factors and potential microbiota modulators.
Understanding how antibiotics influence the microbiota’s impacts on immunotherapy may inform strategies to identify cancer patients that are more likely to respond to cancer treatment.
Iris Dothan, from Rabin Medical Center, Israel, talks about the profiling of patient with pouchitis in order to determine the benefits from microbiome manipulation.
The authors propose a framework to leverage multi-omic datasets obtained from well-defined cohorts and to examine the impact of the GBA on ASD.
The findings of a recent study suggest that there is a causal link between the gut microbiota and infertility.
Jean-Luc Marsat, CEO & Chairman at EverImmune, discusses the research EverImmune carries out in oncology.
Microbiota-based approaches could help researchers expand the therapeutic toolkit for fighting antibiotic resistance and treating tough infections.
The findings of a recent study suggest that even mild cases of COVID-19 can disrupt the gut microbiota.
Pilar Manrique Ronquillo, Research Scientist at Microviable Therapeuthics, talks about the donor-based microbiome therapeutic products research and development.
The findings of a recent study provide insights into how industrialized lifestyles have influenced the composition of the human gut microbiota.
The findings of a recent study may help researchers to characterize the composition of the human gut microbiota in health and disease.
Elisa Cirillo, team lead research data manager at The Hyve, talks about the importance of having high quality data and strong tools to improve the microbiome research and business.
The findings of a recent study suggest that FMT is an effective strategy to mitigate the intestinal side effects of cancer immunotherapy.
Understanding how gut microbes are linked to preclinical Alzheimer’s disease could help to identify markers of disease risk.
Jeroen Raes, from KU Leuven, Belgium, talks about the design of clinical trials for IBD patient with microbiome based therapies.
Lihi Godny, from Rabin Medical Center in Israel, talks about the next steps research has to focus in to improve the FMT efficacy for IBD patients.
A recent review highlights that changes in fear-related mental health conditions are observed when the gut microbiota is altered or removed.
